ALPS Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-91,439
| Closed | -$1.14M | – | 906 |
|
2019
Q1 | $1.14M | Buy |
91,439
+3,952
| +5% | +$49.3K | 0.01% | 298 |
|
2018
Q4 | $990K | Buy |
87,487
+20,567
| +31% | +$233K | 0.01% | 306 |
|
2018
Q3 | $1.25M | Buy |
66,920
+12,298
| +23% | +$230K | 0.01% | 322 |
|
2018
Q2 | $1.41M | Buy |
54,622
+4,272
| +8% | +$110K | 0.01% | 272 |
|
2018
Q1 | $1.13M | Buy |
50,350
+8,751
| +21% | +$196K | 0.01% | 289 |
|
2017
Q4 | $1.04M | Buy |
41,599
+10,176
| +32% | +$255K | 0.01% | 257 |
|
2017
Q3 | $760K | Buy |
31,423
+2,757
| +10% | +$66.7K | 0.01% | 291 |
|
2017
Q2 | $580K | Buy |
28,666
+1,888
| +7% | +$38.2K | ﹤0.01% | 377 |
|
2017
Q1 | $721K | Sell |
26,778
-3,135
| -10% | -$84.4K | 0.01% | 252 |
|
2016
Q4 | $569K | Sell |
29,913
-5,171
| -15% | -$98.4K | ﹤0.01% | 304 |
|
2016
Q3 | $686K | Buy |
35,084
+4,783
| +16% | +$93.5K | 0.01% | 244 |
|
2016
Q2 | $453K | Buy |
30,301
+6,078
| +25% | +$90.9K | ﹤0.01% | 325 |
|
2016
Q1 | $223K | Sell |
24,223
-4,151
| -15% | -$38.2K | ﹤0.01% | 598 |
|
2015
Q4 | $547K | Sell |
28,374
-5,282
| -16% | -$102K | 0.01% | 336 |
|
2015
Q3 | $5K | Buy |
33,656
+12,392
| +58% | +$1.84K | 0.01% | 366 |
|
2015
Q2 | $465K | Buy |
+21,264
| New | +$465K | ﹤0.01% | 579 |
|